|
TUBGCP4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.284200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.484800E-03 |
| Normal-vs-Stage2 |
5.518800E-01 |
| Normal-vs-Stage3 |
3.165000E-01 |
| Normal-vs-Stage4 |
9.932200E-01 |
| Stage1-vs-Stage2 |
3.313400E-01 |
| Stage1-vs-Stage3 |
3.585200E-01 |
| Stage1-vs-Stage4 |
4.037600E-01 |
| Stage2-vs-Stage3 |
8.838200E-01 |
| Stage2-vs-Stage4 |
7.270600E-01 |
| Stage3-vs-Stage4 |
6.000800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.976300E-03 |
| Normal-vs-AfricanAmerican |
1.450760E-01 |
| Normal-vs-Asian |
1.129200E-01 |
| Caucasian-vs-AfricanAmerican |
4.830200E-01 |
| Caucasian-vs-Asian |
8.376200E-01 |
| AfricanAmerican-vs-Asian |
6.541000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.228790E-04 |
| Normal-vs-Female |
3.751800E-01 |
| Male-vs-Female |
9.56429999999786E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.009390E-01 |
| Normal-vs-Extreme_Weight |
1.566630E-04 |
| Normal-vs-Obese |
2.598200E-01 |
| Normal-vs-Extreme_Obese |
2.066200E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.013600E-01 |
| Normal_Weight-vs-Obese |
4.960000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.502200E-01 |
| Extreme_Weight-vs-Obese |
1.990300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.509200E-01 |
| Obese-vs-Extreme_Obese |
2.728600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.941400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.433640E-01 |
| Normal-vs-Age(61-80Yrs) |
8.584200E-04 |
| Normal-vs-Age(81-100Yrs) |
4.536100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.970800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.174000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.248100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.559700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.884780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.169200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.170000E-04 |
| Normal-VS-Type2 PRCC |
5.838000E-02 |
| Normal-VS-KIRP CIMP |
1.425030E-01 |
| Normal-VS-Unclassified PRCC |
3.924400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.295200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.778300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.301810E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.117100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.038800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.395500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.979500E-04 |
| Normal-vs-N1 |
9.190000E-01 |
| Normal-vs-N2 |
9.686000E-01 |
| N0-vs-N1 |
3.583600E-02 |
| N0-vs-N2 |
6.310800E-01 |
| N1-vs-N2 |
9.227400E-01 |
|
|
